Further evidence for the role inflammation plays in obesity comes from studies where inflammation is either inhibited, leading to the prevention of insulin insensitivity and reductions in weight gain [3]–[5], or the inhibition of anti-inflammatory pathways which increases weight gain and the development of the metabolic syndrome [6]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.